HRQOL of Life After ECMO Due to COVID-19.

We intend to prospectively investigate physical and mental state (HRQOL) by means of quantitative telephone interviews after hospital discharge in patients surviving COVID-19 ARDS and ECMO therapy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

ARDS COVID-19 Pneumonia Extracorporeal Membrane Oxygenation

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Medical University of Vienna

Vienna, Austria

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients surviving COVID-19 ARDS and ECMO therapy

Exclusion criteria

no consent

Treatment and study plan

Phone Interview

Other

Phone interview questionnaire

Primary outcomes

HRQOL after COVID-19 ARDS and ECMO therapy

Time frame: 1 year

Health-related quality of life will be delineated by means of a quantitative questionnaire.

Sponsors and collaborators

Lead sponsor

Medical University of Vienna

Other

Registry information

Official study title

Health-related Quality of Life Following Extracorporeal Membrane Oxygenation Due to Coronavirus Disease 2019.

Important dates

Study start: 2022
Primary completion: 2024
Study completion: 2024
First posted: Sep 7, 2022
Registry last updated: Apr 13, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed